Data, mainly from BC, lung cancer, and glioma have suggested many potential mechanisms related to aberrant EGFR signaling, such as high ligands and receptors expression, autocrine signaling loops, constitutive activation of EGFR mutants and crosstalk with other receptors [92]. Here, EGFR is linked to breast cancer.